Engineered immune cells take on Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase trial tests a new treatment for people with advanced melanoma or other solid tumors that have spread. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cancer, and give them back after a short course of chemotherapy. T…
Phase: PHASE1 • Sponsor: Anusha Kalbasi • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC